Fibroblast growth factor 23: A biomarker of kidney function decline
American Journal of Nephrology Apr 09, 2018
Drew DA, et al. - Researchers assessed the links between fibroblast growth factor 23 (FGF-23) and decline in kidney function (defined by estimated glomerular filtration rate (eGFR) decline ≥30% or ≥3 mL/min/year) and incident chronic kidney disease (CKD; incident eGFR <60 mL/min/1.73 m2 and ≥1 mL/min/year decline) in a cohort of well-functioning older adults from the Healthy Aging and Body Composition Study. No consistent association was observed between higher FGF-23 concentrations and decline in kidney function or incident CKD among community-dwelling older adults.
Methods- Serum FGF-23 was assayed using an intact ELISA assay in 2,496 well-functioning older adults of the Healthy Aging and Body Composition Study.
- Cystatin C was assayed at baseline and years 3 and 10 to estimate kidney function.
- The links between FGF-23 and decline in kidney function and incident chronic kidney disease were assessed, adjusting models for demographics, baseline eGFR, urine albumin/creatinine ratio, comorbidity, and serum calcium, phosphorus, 25(OH) vitamin D and parathyroid hormone.
- Study population comprised of 52% female and 38% black, with mean (SD) age of 75 (3) years.
- Data showed 30% decline in 405 persons, >3 mL/min/year decline in 702, and incident CKD in 536.
- Doubling of FGF-23 concentrations was not shown to be related to kidney function decline (OR [95% CI] = 0.98 [0.82–1.19] for ≥30% decline and OR 1.17 [95% CI 1.00–1.37] for ≥3 mL/min/year decline), or incident CKD (incident rate ratio [IRR] 1.05 [95% CI 0.91–1.22]) in fully adjusted continuous models.
- Significant association of the highest quartile of FGF-23 with incident CKD (IRR 1.27 [95% CI 1.02–1.58] for highest vs. lowest quartile) was shown in adjusted quartile analysis.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries